Inspira Technologies Oxy B.H.N. Ltd (IINN)

$0.58 +0.01 (1.45%)
Market Cap 7.40M
Revenue (ttm) 0.00
Net Income (ttm) -11.05M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 522,100
Avg Vol 760,412
Day's Range N/A - N/A
Shares Out 12.62M
Stochastic %K 17%
Beta 2.14
Analysts Strong Buy
Price Target $13.00

Latest News on IINN

Inspira Technologies Generates First Revenues from Deployment of INSPIRA ART100 Systems

Apr 15, 2025, 9:15 AM EDT - 7 days ago

Inspira Technologies Generates First Revenues from Deployment of INSPIRA ART100 Systems

Inspira Technologies Announces Successful Installation of INSPIRA ART100 Systems in Premier U.S. Hospital

Mar 25, 2025, 8:30 AM EDT - 4 weeks ago

Inspira Technologies Announces Successful Installation of INSPIRA ART100 Systems in Premier U.S. Hospital

Inspira Technologies' Innovative Life-Support System to be Showcased at AmSECT 63rd International Conference 2025 in San Diego

Mar 19, 2025, 8:30 AM EDT - 4 weeks ago

Inspira Technologies' Innovative Life-Support System to be Showcased at AmSECT 63rd International Conference 2025 in San Diego

PESG Report: Inspira Technologies' AI-Powered Respiratory System Could Revolutionize Care for 20 Million Annual ICU Patients in Combined $25+ Billion Market

Mar 18, 2025, 1:17 PM EDT - 5 weeks ago

PESG Report: Inspira Technologies' AI-Powered Respiratory System Could Revolutionize Care for 20 Million Annual ICU Patients in Combined $25+ Billion Market

Inspira Technologies Releases CEO Update: Major Milestones Signal Next-Level Respiratory Care

Mar 14, 2025, 7:00 AM EDT - 5 weeks ago

Inspira Technologies Releases CEO Update: Major Milestones Signal Next-Level Respiratory Care

Inspira Technologies Receives Nasdaq Notification Regarding Minimum Bid Requirement

Mar 13, 2025, 4:30 PM EDT - 5 weeks ago

Inspira Technologies Receives Nasdaq Notification Regarding Minimum Bid Requirement

Inspira Technologies Reports Full Year 2024 Financial Results and Provides Business Updates

Mar 11, 2025, 8:30 AM EDT - 6 weeks ago

Inspira Technologies Reports Full Year 2024 Financial Results and Provides Business Updates

PESG Report: Inspira Technologies Breaks new Ground with Positive Clinical Data for AI-Powered Blood Sensor Exceeding Expectations

Mar 5, 2025, 8:46 AM EST - 6 weeks ago

PESG Report: Inspira Technologies Breaks new Ground with Positive Clinical Data for AI-Powered Blood Sensor Exceeding Expectations

Inspira Technologies Announces Positive Results from Clinical Study of HYLA Blood Sensor, Achieving 96% Accuracy

Mar 4, 2025, 8:30 AM EST - 7 weeks ago

Inspira Technologies Announces Positive Results from Clinical Study of HYLA Blood Sensor, Achieving 96% Accuracy

Inspira Achieves Positive Results of Above 95% For Preventing Bloodstream Infections

Feb 11, 2025, 7:00 AM EST - 2 months ago

Inspira Achieves Positive Results of Above 95% For Preventing Bloodstream Infections

PESG Report: Inspira Technologies Strengthens its AI-Powered Blood Sensor with new Capabilities, Intends to Share Clinical Findings Soon

Feb 6, 2025, 8:27 AM EST - 2 months ago

PESG Report: Inspira Technologies Strengthens its AI-Powered Blood Sensor with new Capabilities, Intends to Share Clinical Findings Soon

Inspira Technologies Integrates New Oxygenation Indicator into AI-Powered HYLA Blood Sensor

Feb 5, 2025, 8:30 AM EST - 2 months ago

Inspira Technologies Integrates New Oxygenation Indicator into AI-Powered HYLA Blood Sensor

Inspira™ Introduces Advanced Features for INSPIRA™ ART100, Further Amplifying User and System Support

Jan 27, 2025, 8:30 AM EST - 3 months ago

Inspira™ Introduces Advanced Features for INSPIRA™ ART100, Further Amplifying User and System Support

Inspira™ Technologies Prepares its First Life-Support Systems for Deployment at a Leading U.S. Hospital

Jan 22, 2025, 8:30 AM EST - 3 months ago

Inspira™ Technologies Prepares its First Life-Support Systems for Deployment at a Leading U.S. Hospital

Inspira™ Announces the Appointment of Tal Parnes as the New Chairman of the Board, Bringing Vast Experience in the Medical Technology and Pharmaceutical Sectors

Jan 21, 2025, 8:30 AM EST - 3 months ago

Inspira™ Announces the Appointment of Tal Parnes as the New Chairman of the Board, Bringing Vast Experience in the Medical Technology and Pharmaceutical Sectors

Inspira™ Technologies Collaborates With Zriha Medical To Launch Cutting-Edge Production Line

Jan 17, 2025, 8:30 AM EST - 3 months ago

Inspira™ Technologies Collaborates With Zriha Medical To Launch Cutting-Edge Production Line

Inspira™ Technologies Unveils Modular Configuration for Revolutionary VORTX™ Blood Oxygenation Delivery Technology

Jan 14, 2025, 8:30 AM EST - 3 months ago

Inspira™ Technologies Unveils Modular Configuration for Revolutionary VORTX™ Blood Oxygenation Delivery Technology

Inspira™ Preparing Production in Response to Spread of Respiratory Virus in China

Jan 10, 2025, 6:15 AM EST - 3 months ago

Inspira™ Preparing Production in Response to Spread of Respiratory Virus in China

Inspira™ Technologies Flagship Technology to be Showcased at Arab Health Expo 2025 in Dubai

Jan 7, 2025, 8:15 AM EST - 3 months ago

Inspira™ Technologies Flagship Technology to be Showcased at Arab Health Expo 2025 in Dubai

Inspira™ Announces Pricing of $3.2M Private Placement by New and Existing Investors of the Company

Dec 27, 2024, 10:09 AM EST - 4 months ago

Inspira™ Announces Pricing of $3.2M Private Placement by New and Existing Investors of the Company

Inspira™ Technologies Delivers Systems to Leading Distributor for U.S. Deployment

Dec 16, 2024, 8:30 AM EST - 4 months ago

Inspira™ Technologies Delivers Systems to Leading Distributor for U.S. Deployment

Inspira™ Expands HYLA™ Blood Sensor Technology into Personalized Blood Lab Testing for Rapid Detection of Serious Medical Conditions

Dec 10, 2024, 8:00 AM EST - 4 months ago

Inspira™ Expands HYLA™ Blood Sensor Technology into Personalized Blood Lab Testing for Rapid Detection of Serious Medical Conditions

Inspira™ Collaborates with New York's Westchester Medical Center to Evaluate the INSPIRA™ ART100 Functionality and Performance in Clinical Scenarios

Dec 4, 2024, 7:00 AM EST - 4 months ago

Inspira™ Collaborates with New York's Westchester Medical Center to Evaluate the INSPIRA™ ART100 Functionality and Performance in Clinical Scenarios

Join Inspira™ Technologies' Live Investor Webinar and Q&A Session on November 11

Nov 8, 2024, 9:11 AM EST - 5 months ago

Join Inspira™ Technologies' Live Investor Webinar and Q&A Session on November 11

Inspira™ Announces Establishment of Distribution Facility to Support U.S. Deployment of INSPIRA™ ART100

Oct 24, 2024, 8:30 AM EDT - 6 months ago

Inspira™ Announces Establishment of Distribution Facility to Support U.S. Deployment of INSPIRA™ ART100

Inspira™ Announces Development of New Disposable Kit with Built-In Performance Monitoring Mechanism

Oct 9, 2024, 8:00 AM EDT - 6 months ago

Inspira™ Announces Development of New Disposable Kit with Built-In Performance Monitoring Mechanism

Inspira™ Launches INSPIRA™ ART100 at the World's Largest Extracorporeal Life Support Conference

Sep 24, 2024, 8:30 AM EDT - 7 months ago

Inspira™ Launches INSPIRA™ ART100 at the World's Largest Extracorporeal Life Support Conference

Inspira™ Secures a Second U.S. Patent Approval for Orbiting Blood Oxygenation Delivery System

Sep 13, 2024, 7:30 AM EDT - 7 months ago

Inspira™ Secures a Second U.S. Patent Approval for Orbiting Blood Oxygenation Delivery System

Inspira™ to Publish HYLA™ Clinical Results in Fourth Quarter 2024

Aug 28, 2024, 8:45 AM EDT - 8 months ago

Inspira™ to Publish HYLA™ Clinical Results in Fourth Quarter 2024

Inspira™ Technologies Announces FDA Listing and Market Readiness of New Product

Aug 22, 2024, 8:00 AM EDT - 8 months ago

Inspira™ Technologies Announces FDA Listing and Market Readiness of New Product

Inspira™ Approached by Large Medical Company to Evaluate Operation of their Key Product with INSPIRA™ ART100 - Results Exceed 100% at Maximum Flow

Aug 13, 2024, 8:00 AM EDT - 9 months ago

Inspira™ Approached by Large Medical Company to Evaluate Operation of their Key Product with INSPIRA™ ART100 - Results Exceed 100% at Maximum Flow

Inspira™ Technologies Introduces the INSPIRA Cardi-ART, Aiming to Provide Oxygen to the Brain During Cardiac Arrest

Jul 30, 2024, 7:30 AM EDT - 9 months ago

Inspira™ Technologies Introduces the INSPIRA Cardi-ART, Aiming to Provide Oxygen to the Brain During Cardiac Arrest

Inspira™ Receives Israeli Regulatory Approval for the INSPIRA™ ART100 System

Jul 11, 2024, 8:30 AM EDT - 10 months ago

Inspira™ Receives Israeli Regulatory Approval for the INSPIRA™ ART100 System

Inspira™ Announces Business Plan Targets

Jun 20, 2024, 9:25 AM EDT - 10 months ago

Inspira™ Announces Business Plan Targets

Inspira™ Introduces Advanced Life Support Solutions to Key International Leaders at the Annual iECOs Conference in Israel

Jun 17, 2024, 8:30 AM EDT - 11 months ago

Inspira™ Introduces Advanced Life Support Solutions to Key International Leaders at the Annual iECOs Conference in Israel

Inspira™ Receives First Ever Purchase Order for INSPIRA™ ART100 Systems in the U.S.

Jun 13, 2024, 8:30 AM EDT - 11 months ago

Inspira™ Receives First Ever Purchase Order for INSPIRA™ ART100 Systems in the U.S.

Inspira™ to Exhibit the FDA Cleared INSPIRA™ ART100 System at a World-Renowned Event in the Sector

Jun 5, 2024, 8:30 AM EDT - 11 months ago

Inspira™ to Exhibit the FDA Cleared INSPIRA™ ART100 System at a World-Renowned Event in the Sector

Inspira™ Technologies Announces Business Targets Presentation Following FDA Clearance and Significant Developments

May 30, 2024, 8:30 AM EDT - 11 months ago

Inspira™ Technologies Announces Business Targets Presentation Following FDA Clearance and Significant Developments

INSPIRA™ ART100 Receives FDA 510(k) Clearance

May 28, 2024, 9:25 AM EDT - 11 months ago

INSPIRA™ ART100 Receives FDA 510(k) Clearance

Inspira™ Announces Start of Production of the INSPIRA™ ART100

May 2, 2024, 9:18 AM EDT - 1 year ago

Inspira™ Announces Start of Production of the INSPIRA™ ART100

Inspira™ Receives CSA Certification of Compliance to U.S. Standards for the INSPIRA™ ART100

Apr 25, 2024, 8:00 AM EDT - 1 year ago

Inspira™ Receives CSA Certification of Compliance to U.S. Standards for the INSPIRA™ ART100

Inspira™ Signs Term Sheet for Use of INSPIRA™ ART100 Device in Organ Transplant Procedures

Apr 16, 2024, 8:42 AM EDT - 1 year ago

Inspira™ Signs Term Sheet for Use of INSPIRA™ ART100 Device in Organ Transplant Procedures

Inspira™ and Ennocure In Vitro Study Results Show 100% Prevention of Bacterial Growth that Causes Bloodstream Infections

Apr 10, 2024, 8:24 AM EDT - 1 year ago

Inspira™ and Ennocure In Vitro Study Results Show 100% Prevention of Bacterial Growth that Causes Bloodstream Infections

Inspira™ Announces Program to Pioneer the Applicable Use of the INSPIRA™ ART100 Device for an Artificial Womb

Apr 3, 2024, 8:30 AM EDT - 1 year ago

Inspira™ Announces Program to Pioneer the Applicable Use of the INSPIRA™ ART100 Device for an Artificial Womb

Inspira™ Announces $1.65 Million Registered Direct Offering of Ordinary Shares by Inspira CEO's Mother with Leading Fund Manager

Apr 1, 2024, 8:00 AM EDT - 1 year ago

Inspira™ Announces $1.65 Million Registered Direct Offering of Ordinary Shares by Inspira CEO's Mother with Leading Fund Manager

Inspira™ Technologies Reports Full Year 2023 Financial Results

Mar 25, 2024, 9:20 AM EDT - 1 year ago

Inspira™ Technologies Reports Full Year 2023 Financial Results

Inspira™ Announces AMAR Regulatory Submission of the INSPIRA™ ART100, to Enter the Southeast Asia and South American Markets

Mar 18, 2024, 7:00 AM EDT - 1 year ago

Inspira™ Announces AMAR Regulatory Submission of the INSPIRA™ ART100, to Enter the Southeast Asia and South American Markets

Inspira™ Releases New Data Demonstrating Superiority of its Core Technology, Across Key Endpoints of HMSS Indicator

Mar 12, 2024, 8:00 AM EDT - 1 year ago

Inspira™ Releases New Data Demonstrating Superiority of its Core Technology, Across Key Endpoints of HMSS Indicator

Inspira™ Announces Plans to Report the Primary Results for a Core Blood Oxygenation Technology Within Days

Mar 4, 2024, 9:20 AM EST - 1 year ago

Inspira™ Announces Plans to Report the Primary Results for a Core Blood Oxygenation Technology Within Days